| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
pharmaceutical_companies:janssen [2022/02/21 19:06]
liam [Payments to Organizations] | pharmaceutical_companies:janssen [2023/06/04 20:28] (current)
liam |
|---|
| |
| Janssen is distributing a recombinant "non replicating viral vector" [[:COVID-19 vaccines|COVID-19 vaccine]] product in the United States and other countries worldwide.((//Janssen (Johnson & Johnson): Ad26.COV2.S.// COVID-19 Vaccine Tracker. Retrieved January 18, 2022, from https://archive.ph/nPhNi)) ((National Center for Immunization and Respiratory Diseases. (2021, November 4). //Administration Overview for Johnson & Johnson’s Janssen COVID-19 Vaccine.// U.S. Centers for Disease Control and Prevention (CDC). Retrieved December 5, 2021, from https://archive.ph/svpaI)) It is approved but not widely distributed in Canada.((Health Canada. (2021, March 5). //Janssen COVID-19 Vaccine.// Government of Canada. Retrieved December 5, 2021, from https://archive.ph/2cl9Z)) | Janssen is distributing a recombinant "non replicating viral vector" [[:COVID-19 vaccines|COVID-19 vaccine]] product in the United States and other countries worldwide.((//Janssen (Johnson & Johnson): Ad26.COV2.S.// COVID-19 Vaccine Tracker. Retrieved January 18, 2022, from https://archive.ph/nPhNi)) ((National Center for Immunization and Respiratory Diseases. (2021, November 4). //Administration Overview for Johnson & Johnson’s Janssen COVID-19 Vaccine.// U.S. Centers for Disease Control and Prevention (CDC). Retrieved December 5, 2021, from https://archive.ph/svpaI)) It is approved but not widely distributed in Canada.((Health Canada. (2021, March 5). //Janssen COVID-19 Vaccine.// Government of Canada. Retrieved December 5, 2021, from https://archive.ph/2cl9Z)) |
| | |
| | On June 1, 2023, the [[:Food and Drug Administration]] revoked the EUA for Janssen's product.((Marks, P. (2023, June 1). //Re: Revocation of EUA 27205 - Janssen COVID-19 Vaccine.// Food and Drug Administration. https://web.archive.org/web/20230603070204/https://www.fda.gov/media/169003/download)) |
| |
| ===== Payments from Janssen ===== | ===== Payments from Janssen ===== |
| ^ Name ^ Type ^ Amount ^ Description ^ | ^ Name ^ Type ^ Amount ^ Description ^ |
| | [[:SickKids]] | Donation | $100,000.00 - $999,999.00 | Donations to the SickKids Foundation.((//Annual Report 2020-2021.// (2021). SickKids. https://www.sickkids.ca/siteassets/about/about-sickkids/sickkids-annual-report-2020-2021.pdf)) | | | [[:SickKids]] | Donation | $100,000.00 - $999,999.00 | Donations to the SickKids Foundation.((//Annual Report 2020-2021.// (2021). SickKids. https://www.sickkids.ca/siteassets/about/about-sickkids/sickkids-annual-report-2020-2021.pdf)) | |
| | [[:University Hospitals Kingston Foundation]] | Donation | $50,000.00 – $99,999.00 | Cumulative donations up to December 31, 2019((//Recognizing your contribution.// University Hospitals Kingston Foundation. Retrieved February 21, 2022, from https://www.uhkf.ca/Your-Impact/Recognizing-Your-Contribution)) | | | [[:University Hospitals Kingston Foundation]] | Donation | $50,000.00 – $99,999.00 | Cumulative donations up to December 31, 2019.((//Recognizing your contribution.// University Hospitals Kingston Foundation. Retrieved February 21, 2022, from https://www.uhkf.ca/Your-Impact/Recognizing-Your-Contribution)) | |
| | |
| | {{tag>Pharmaceutical_Companies}} |
